12th International Conference on HHV-6 & 7 Announced The 12th International Conference on HHV-6 & 7 will convene in Japan at the Himeji Culture and Convention Center in March 2025.
Co-infection of HHV-6A and EBV results in a 6.7 fold increased risk of developing multiple sclerosis The increased risk occurred only in adults who were infected with EBV after their teenage years, and had elevated EBNA-1 antibodies.
Metformin reduces HHV-6A replication in T cells by activating AMPK Conversely, HHV-6A infection increases viral replication by inhibiting AMPK and enhancing mTOR signaling and glycolysis.
Reactivation of a transplant recipient’s iciHHV-6B resulted in an active infection of his donated liver Investigators from the University of Helsinki used highly sophisticated techniques to establish that the donor’s integrated virus reactivated and then infected the graft. This thorough investigation highlights the potential pathological impact of iciHHV-6B in transplantation.
